European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer

by Marie Weil
January 12, 2021
A A
Share on LinkedinShare on Twitter
  • uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis aid pathologists in providing fast and accurate patient diagnoses in breast cancer
  • In combination with the VENTANA DP 200 slide scanner and Roche uPath enterprise software, the new algorithms provide innovative digital pathology solutions to advance personalised healthcare
  • Nearly 2.3 million new cases of breast cancer are diagnosed worldwide each year.1 About 15 to 20 percent of women diagnosed with breast cancer are HER2 positive.2

Basel, 11 January 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient. The image analysis algorithms use artificial intelligence to support pathologists in making fast and accurate patient diagnoses in breast cancer.

Amplification in the HER2 gene, which occurs in as many as 20 percent of the nearly 2.3 million cases of breast cancer diagnosed globally each year, is responsible for aggressive growth in some patients. Identifying this amplification is important in determining which patients may benefit from targeted treatment.1,2

“About 15 to 20 percent of women diagnosed with breast cancer are HER2 positive, which makes fast and accurate diagnosis critical,” said Thomas Schinecker, CEO Roche Diagnostics. “Roche is continuing to innovate in HER2 diagnostics by providing precise information through image analysis algorithms for pathology decision support.”

uPath HER2 (4B5) image analysis for breast cancer helps pathologists to quickly determine whether tumors are positive for the HER2 biomarker, highlighting positively stained tumor cell membranes with a clear visual overlay for easy reference. uPath HER2 Dual ISH image analysis for breast cancer assists the pathologist in the determination of HER2 gene amplification. A heatmap is provided to guide pathologists to areas of interest where the algorithm can identify cells to inform the determination of a treatment strategy.

Validated for use with the VENTANA HER2 (4B5) assay and the VENTANA HER2 Dual ISH DNA Probe Cocktail, the algorithms are ready-to-use and integrated within the Roche uPath enterprise software.The uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis algorithms for breast cancer expand Roche’s digital pathology portfolio to empower precision diagnosis. Roche is continuing to innovate in HER2 diagnostics through image analysis algorithms that provide an actionable assessment of scanned slide images that are objective and reproducible.

Tags: < Innovation

Related Industries

Health

Philips launches AI-powered CT system to accelerate routine radiology and high-volume screening programs

May 18, 2023
Health

Siemens Healthineers opens state-of-the-art education and development center in Erlangen, Germany

May 18, 2023
Health

Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology

May 11, 2023
Health

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

May 9, 2023
Health

Changes in Merck Executive Board

May 9, 2023
Health

Health Care Collaboration in Denmark Aims to Reduce Medical Waste

May 9, 2023

Philips launches AI-powered CT system to accelerate routine radiology and high-volume screening programs

May 18, 2023

...

BASF partners with BEAUTYSTREAMS to further expand its D’lite digital service for the personal care industry

May 24, 2023

...

Barclays announces new leadership for Global Equities

May 24, 2023

...

Boehringer Ingelheim and German Chancellor Olaf Scholz lay the foundation stone for 285 million EUR innovation center

May 3, 2023

...

Changes in Merck Executive Board

May 9, 2023

...

Gitte van Haaren appointed as CEO of ABN AMRO Hypotheken Groep B.V.

May 4, 2023

...

Cargill expands its award-winning regenerative agriculture program to Europe

May 24, 2023

...

Health Care Collaboration in Denmark Aims to Reduce Medical Waste

May 9, 2023

...

Nestlé announces retirement of Magdi Batato, Stephanie Pullings Hart appointed as next Head of Operations

May 24, 2023

...

Hydrogen fuel cell trucks to decarbonise Toyota logistics in Europe

May 10, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist